These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies. Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010 [TBL] [Abstract][Full Text] [Related]
26. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Ekiert DC; Kashyap AK; Steel J; Rubrum A; Bhabha G; Khayat R; Lee JH; Dillon MA; O'Neil RE; Faynboym AM; Horowitz M; Horowitz L; Ward AB; Palese P; Webby R; Lerner RA; Bhatt RR; Wilson IA Nature; 2012 Sep; 489(7417):526-32. PubMed ID: 22982990 [TBL] [Abstract][Full Text] [Related]
27. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes. Che Z; Olson NH; Leippe D; Lee WM; Mosser AG; Rueckert RR; Baker TS; Smith TJ J Virol; 1998 Jun; 72(6):4610-22. PubMed ID: 9573224 [TBL] [Abstract][Full Text] [Related]
28. Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface. Zhu X; Han J; Sun W; Puente-Massaguer E; Yu W; Palese P; Krammer F; Ward AB; Wilson IA Proc Natl Acad Sci U S A; 2022 May; 119(21):e2200821119. PubMed ID: 35594401 [TBL] [Abstract][Full Text] [Related]
29. Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations Davis AKF; McCormick K; Gumina ME; Petrie JG; Martin ET; Xue KS; Bloom JD; Monto AS; Bushman FD; Hensley SE J Virol; 2018 Oct; 92(19):. PubMed ID: 30045982 [TBL] [Abstract][Full Text] [Related]
30. Subtype- and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin. Stray SJ; Pittman LB Virol J; 2012 May; 9():91. PubMed ID: 22569196 [TBL] [Abstract][Full Text] [Related]
31. Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody. Chandramouli S; Ciferri C; Nikitin PA; Caló S; Gerrein R; Balabanis K; Monroe J; Hebner C; Lilja AE; Settembre EC; Carfi A Nat Commun; 2015 Sep; 6():8176. PubMed ID: 26365435 [TBL] [Abstract][Full Text] [Related]
32. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Skehel JJ; Wiley DC Annu Rev Biochem; 2000; 69():531-69. PubMed ID: 10966468 [TBL] [Abstract][Full Text] [Related]
33. Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites. Winarski KL; Thornburg NJ; Yu Y; Sapparapu G; Crowe JE; Spiller BW Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9346-51. PubMed ID: 26170302 [TBL] [Abstract][Full Text] [Related]
34. Structural evidence for recognition of a single epitope by two distinct antibodies. Fleury D; Daniels RS; Skehel JJ; Knossow M; Bizebard T Proteins; 2000 Sep; 40(4):572-8. PubMed ID: 10899782 [TBL] [Abstract][Full Text] [Related]
35. Discovering neutralizing antibodies targeting the stem epitope of H1N1 influenza hemagglutinin with synthetic phage-displayed antibody libraries. Tung CP; Chen IC; Yu CM; Peng HP; Jian JW; Ma SH; Lee YC; Jan JT; Yang AS Sci Rep; 2015 Oct; 5():15053. PubMed ID: 26456860 [TBL] [Abstract][Full Text] [Related]
36. Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies. Abbadi N; Nagashima K; Pena-Briseno A; Ross TM; Mousa JJ J Virol; 2022 Aug; 96(16):e0089622. PubMed ID: 35916534 [TBL] [Abstract][Full Text] [Related]
37. Isolation of recombinant phage antibodies targeting the hemagglutinin cleavage site of highly pathogenic avian influenza virus. Dong J; Sakurai A; Nomura N; Park EY; Shibasaki F; Ueda H PLoS One; 2013; 8(4):e61158. PubMed ID: 23577205 [TBL] [Abstract][Full Text] [Related]
38. Structure of the apo anti-influenza CH65 Fab. Lee PS; Arnell AJ; Wilson IA Acta Crystallogr F Struct Biol Commun; 2015 Feb; 71(Pt 2):145-8. PubMed ID: 25664786 [TBL] [Abstract][Full Text] [Related]
39. Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses. Carter DM; Darby CA; Lefoley BC; Crevar CJ; Alefantis T; Oomen R; Anderson SF; Strugnell T; Cortés-Garcia G; Vogel TU; Parrington M; Kleanthous H; Ross TM J Virol; 2016 May; 90(9):4720-4734. PubMed ID: 26912624 [TBL] [Abstract][Full Text] [Related]
40. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses. Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]